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1. Introduction 
Diet has been suggested to play a role in the etiology and pathogenesis of psoriasis (Araujo 
et al., 2009; Wolters, 2005). Periods of fasting, a hypocaloric and vegetarian diet have been 
associated with an improvement in symptoms due to changes in the metabolism of 
polyunsaturated fatty acids (PUFAs) and an influence on the profile of eicosanoids, leading 
to suppression of the inflammatory process (Lithell et al., 1983; Rucevic et al., 2003; Wolters, 
2005). The consumption of alcoholic beverages is prevalent among patients with psoriasis 
and is the greatest cause of the high mortality rate among individuals with moderate to 
severe forms of the disease and should therefore be avoided (Chistophers, 2001; Poikolainen 
et al., 1990; Smith & Fenske, 2000; Wolters, 2005). According to several authors, calcitriol (the 
active form of vitamin D) and its analogs have anti-proliferation, pro-differentiation and 
immune-regulating properties that may inhibit the growth and maturation of keratinocytes, 
with oral supplementation often suggested for patients who do not topically use calcitriol 
(Andorini, 2002; Holick, 2003; Wolters, 2005). 
The skin acts as an interface between the body and surrounding environment, thus the skin 
is constantly exposed to both endogenous and exogenous pro-oxidants, leading to the 
generation of harmful oxidant species. Oxidative stress and the generation of excessive free 
radicals have been related to skin inflammation in psoriasis. Patients with this condition 
have reduced plasma levels of ǃ-carotene and ǂ-tocopherol as well as a decline in serum 
selenium and high concentrations of malondialdehyde, which is a marker of lipid 
peroxidation in the plasma and red blood cells (Briganti & Picardo, 2003; Azzini et al., 1995; 
Serwin et al., 2003).  
Data from literature indicates that the topical application or oral administration of 
antioxidants is suggested as preventive therapy for the natural aging of the skin and cancer 
caused by ultraviolet rays (Briganti & Picardo, 2003). With regard to lipids, studies have 
demonstrated the anti-inflammatory effect of fish oil in individuals with psoriasis, as diets 
rich in omega 3 modify the metabolism of PUFAs, thereby influencing the profile of 
eicosanoids, which leads to the suppression of the inflammatory process (Smith & Fenske, 
2000). A number of authors report an association between latent sensitivity to gluten (pre-
celiac disease state) and different skin diseases, including psoriasis, suggesting a gluten-free 
diet may provide beneficial effects (Duggan, 2004; Humbert et al., 2006; Leffler et al., 2003; 
Michaelsson et al., 2003; Nelson, 2002; Wolters, 2005). 
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The aforementioned data underscore the importance of studies on psoriasis, especially with 
regard to the influence of nutrition on the etiopathogenesis and treatment of this condition.  
2. Influence of calorie intake, periods of fasting and vegetarian diet 
A number of studies report that symptoms of inflammatory disease, such as rheumatoid 
arthritis, can improve with a hypocaloric diet or during periods of fasting (Muller et al., 
2001; Palmblad et al., 1991). Similarly, the prevalence and severity of psoriasis were shown 
to improve during periods of fasting and a hypocaloric diet,suggesting diet to be an 
important consideration for theprevention and treatment of the moderate non-pustular form 
of the disease (Rucevic et al., 2003; Wolters, 2005) 
While various mechanisms have been discussed, the direct cause of these positive effects on 
the symptoms of psoriasis remains unknown (Wolters, 2005). The most important reason is 
likely a reduction in arachidonic acid (AA) intake, resulting in a lower production of 
inflammatory eicosanoids. During the fasting state, a reduction in the activation of TCD4 
cells and an increase in the number and/or function of the anti-inflammatory cytokine 
interleukin 4 have been observed; Calorie restriction leads to a reduction in oxidative stress 
(Fraser et al., 1999; Wolters, 2005). However, the few studies that have addressed the effect 
of caloric restriction on psoriasis offer inconsistent data on the benefits of this conduct over a 
long period of time (Lithell et al., 1983; Rucevic et al., 2003). The results of evaluations 
carried out during World War I revealed that individuals with psoriasis experienced 
significant improvement during calorie restriction, with the recurrence of skin lesions after 
the reintroduction of a normal diet (Ricketts et al., 2010). 
A vegetarian diet may be beneficial to all patients with psoriasis due to the reduction in AA 
intake and consequent reduction in the formation of inflammatory eicosanoids (Fraser et al., 
1999). 
3. Polyunsaturated fatty acids 
Lipids are macronutrients that perform energy, structural and hormonal functions in 
organisms. Fatty acids are monocarboxylic acids with a hydrocarbon chain of variable size 
and double bonds between carbon atoms. These substances are classified as 
monounsaturated and polyunsaturated, depending on the number of double bonds they 
contain. Fatty acids are integral compounds of nearly all lipids. Two series of PUFAs are 
differentiated, depending on the location of the first double carbon bond at the methyl 
radical. Linoleic acid, which is an essential fatty acid, belongs to the omega 6 family and is 
found in a large quantity of oleaginous seeds; this acid can be converted into AA, which is 
prinicipally derived from meat and egg sources (Dutra-de-Oliveira, 2000). Eicosapentaenoic 
acid (EPA) and docosahexaenoic acid are the most abundant omega 3 fatty acids in food and 
are found mainly in cold-water fish, such as mackerel, sardine, salmon, herring, etc. 
(Wolters, 2005). 
Besides their function in the phospholipid membrane, PUFAs are needed for the formation 
of eicosanoids, which are metabolic regulators (Jones & Papamandjaris, 2001). AA is a 
precursor of prostaglandins, leukotrienes and other compounds that have important 
functions in inflammation and the regulation of immunity, whereas EPA derivatives exhibit 
anti-inflammatory properties (Calder, 2001). High concentrations of AA and its pro-
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inflammatory metabolites have been observed in psoriatic lesions as well as in other auto-
immune and inflammatory disorders. Therefore, one treatment option for psoriasis  may be 
the replacement of AA with an alternative fatty acid, especially EPA, which is metabolized 
through the same enzymatic pathways as AA (Mayser et al., 2002; Wolters, 2005). 
Fish oil (omega 3), has been observed to change the serum and lipid composition of 
epidermal and blood cell membranes, which rationalizes its use in the treatment of psoriasis.  
High levels of AA are found in psoriatic lesions and it is believed that its metabolite, 
leukotriene B4, may be the mediator of inflammation in psoriasis (Ricketts et al., 2010). Thus, 
when omega 3 fatty acids are metabolized by cyclooxygenase or lipoxygenase in place of 
AA in the cell membranes, these substances may assist in reducing inflammation (Ricketts et 
al., 2010). 
Conflicting results are reported regarding the effect of the oral supplementation of omega 3 
on this disease and there are no clear findings regarding the dose to be employed (Mayser et 
al., 2002; Wilkinson, 1990). In vitro studies report that the addition of fish oil to the diet of 
individuals with psoriasis leads to an increase in EPA in relation to AA in the plasma and 
platelets, with a significant reduction in the synthesis of leukotriene B4 (Ricketts et al., 2010) 
Initial studies involving different amounts of EPA ranging from 3.6 to 14 grams per day for 
periods of six weeks to six months report some clinical improvement with minimal side 
effects; however, lower doses for a shorter period of time are reported to offer no significant 
improvement (Maurice et al., 1987; Ziboh et al., 1986; Kragballe & Fogh, 1989; Kojima et al., 
1989). The majority of studies report positive results; however, less effective results are 
reported in randomized, controlled trials (Wolters, 2005). Despite the inconsistent results, 
the consumption of fish rich in omega 3 is recommended. Moreover, parenteral infusions of 
omega 3 may be beneficial to patients hospitalized with acute psoriasis (Wolters, 2005). 
4. Gluten 
Celiac disease is an enteropathy associated with different extra-intestinal manifestations, 
such as anemia, transaminase elevation, osteopenia, neurological conditions, emotional and 
psychiatric disorders, auto-immune disease and dermatological problems. This disease is  
characterized by an allergy to gluten (a protein found in wheat, oats, rye and barley), 
leading to malabsorption and atrophy of the intestinal villi, which improves with a gluten-
free diet (Abenavoli et al., 2006). 
This gluten-sensitive enteropathy tends to bemildly symptomatic and even  
asymptomatic, which may explain the association between latent gluten sensitivity and 
psoriasis (Wolters, 2005). A number of studies report an association between celiac disease 
and psoriasis (Michaelsson et al., 2000; Woo et al., 2004). According to some authors, 
however, this association is controversial due to currently limited data (Addolorato et al., 
2003; Collin & Reunal, 2003). Since both celiac disease and psoriasis are related to T helper 
1 (Th1) cytokines,  this association could be caused by the activation of Th1 by the 
interleukins IL1 and IL8, stemming from the rapid division of keratinocytes (Ojetti et al., 
2003). 
There is no consensus among current literature regarding the high prevalence of patients 
with psoriasis and antibodies associated to celiac disease (Ricketts et al., 2010).  Thus, there 
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is a need for prospective studies in order to determine the incidence of celiac disease and the 
real percentage of increased levels of antigliadin, antiendomysial and anti-tissue 
transglutaminase antibodies in patients with psoriasis (Ricketts et al., 2010). 
A gluten-free diet can improve skin lesions even in patients without celiac disease but with 
the antigliadin antibodies IgA and IgG, which are important to the diagnosis of celiac 
disease (Michaelsson et al., 2003). Likewise, studies indicate that a gluten-free diet leads to 
an improvement in rheumatoid arthritis, which is another chronic inflammatory disease 
(Hafstrom et al., 2001). Data remains scarce in regards to  the mechanisms involved in the 
association between celiac disease, psoriasis and a gluten-free diet in skin lesions. A number 
of hypotheses have been raised, such as an alteration in intestinal permeability, immune 
mechanisms and vitamin D deficiency (Abenavoli et al., 2006). 
5. Oxidative stress and antioxidants 
The skin is constantly exposed to oxidants, which leads to the formation of harmful reactive 
oxygen species (Briganti & Picardo, 2003). Oxidative stress and the increased formation of 
free radicals have been related to skin inflammation and are reported to be among the most 
important factors in the pathogenesis of psoriasis (Kiymat et al., 2003; Rocha et al., 2004; 
Relhan et al., 2002; Wolters, 2005). Studies demonstrate that individuals with psoriasis have 
high concentrations of malondialdehyde, OuvirLer foneticamentea marker of lipid 
peroxidation, and is compromised antioxidant status, with reduced levels of -carotene, -
tocopherol and selenium (Azzini et al., 1995; Briganti & Picardo, 2003; Serwin et al., 2003).  
High alcohol intake (stemming from the psychosocial impact of the disease) and either 
active or passive smoking are among some of the factors that can increase oxidative stress 
and reduce levels of natural antioxidants in individuals with a history of the disease for 
more than three years (Lecomte et al., 1994; Mckenzie, 2000; Monk & Neil, 1986; Naldi et al., 
1992). The consumption of fruit and vegetables may be beneficial to such individuals due to 
the high antioxidant content, such as karotenoids, flavonoids and vitamin C, as an adequate 
antioxidant status is considered useful to the prevention of imbalance between oxidative 
stress and antioxidant defense (Naldi et al., 1996; Wolters, 2005). However, few studies have 
investigated the effects of antioxidant supplementation on the symptoms of psoriasis 
(Wolters, 2005). 
6. Selenium 
Selenium is an essential trace element with immune-modulating and anti-proliferative 
properties, with an influence over the immune response whether through a change in the 
expression of cytokines and respective receptors or by making immune cells more resistant 
to oxidative stress (Celerier et al., 1995; Roy et al., 1992; Spallholtz et al., 1990). Moreover, 
data  indicates that patients with inflammatory skin diseases, skin cancer, malignant 
melanoma and cutaneous T-cell lymphoma have low concentrations of selenium (Clark et 
al., 1984; Deffuant et al., 1984; Hinks et al., 1987; Michaelsson & Edqvist, 1984).    
The low concentration of selenium found in patients with psoriasis may be a risk factor for 
the development of the disease. However, there are few studies on the role of this element in 
the pathogenesis (Hinks et al., 1987; Fairris et al., 1989; Michaelsson et al., 1989; Harvima et 
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al., 1993; Pinton et al., 1995; Azzini et al., 1995). Low levels of selenium are related to the 
severity of psoriasis and may occur due to low food intake or excessive flaking of the skin 
(Serwin et al., 2003). Serwin et al. (2003) found that selenium levels were significantly lower 
in patients with a diagnosis of psoriasis for more than three years in comparison to healthy 
volunteers (38.69 vs 48.41; p < 0.05).  
Kharaeva et al. (2009) demonstrated for the first time that the combination of conventional 
therapy and supplementation with vitamin E, co-enzyme Q10 and selenium resulted in an 
improvement in the clinical condition of patients with severe psoriasis as well as a reduction 
in oxidative stress. Supplementation using inorganic forms of selenium (sodium selenite 
and selenate) is also reported to lead to clinical improvement in patients with psoriasis 
(Fairris et al., 1989; Pinton et al., 1995). 
7. Vitamin D 
Vitamin D is a pro-hormone that can be produced from 7-dehydrocholesterol through the 
exposure of skin to ultraviolet B rays of the sun. Besides its importance in the homeostasis of 
calcium and bone metabolism, calcitriol (the active form of vitamin D) has effects on more 
than 30 types of tissue, including skin (Wolters, 2005). Vitamin D plays an important role in 
reducing the risk of a number of chronic diseases, such as auto-immune diseases, infectious 
diseases, cardiovascular diseases and some forms of cancer (breast, colon-rectal and prostate 
cancer) (Fu &Vender, 2011). 
Vitamin D plays an essential role in cell proliferation, differentiation, apoptosis and 
angiogenesis.Vitamin D also has beneficial effects on inflammatory diseases medicated by 
Th1 lymphocytes, such as diabetes, psoriasis, Crohn’s disease and multiple sclerosis 
(Cantorna et al., 2004; Holick, 2007; Ikeda et al., 2010). Vitamin D has proven to be highly 
effective in the treatment of psoriasis, as patients having received vitamin D for the 
treatment of osteoporosis exhibited an improvement in psoriasis (Abramovits, 2009; Smith 
et al., 2009; Van De Kerkhof, 2005). Due to the function of calcitriol and its analogs in 
psoriasis, oral supplementation with vitamin D should be considered in patients who do not 
make use of topical treatment with this vitamin, as vitamin D deficiency is frequent in these 
individuals (Holick, 2003; Wolters, 2005). 
8. Vitamin B12 
Data from the literature demonstrates the efficacy of using intramuscular and systemic 
vitamin B12 in patients with psoriasis in addition to the positive effects of topical vitamin 
B12 (Ricketts et al., 2010). 
9. Zinc 
Zinc deficiency has been associated with the presence of psoriatic plaque (Smith et al., 2009). 
However, there is little evidence on the benefits of oral supplementation as of yet (Burrows 
et al., 1994). Moreover, there are no recommendations regarding the amount or chemical 
form that offers the best beneficial effects. 
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10. Alcoholic beverages 
The first studies on the association between psoriasis and the consumption of alcoholic 
beverages emerged in 1963. While some investigations have failed to demonstrate such an 
association, recent studies have shown a significant correlation (Wolf et al., 1999). Besides 
contributing to the development of psoriatic plaque, alcohol intake is involved in triggering 
periods of exacerbation, associated with a reduced response to treatment and the risk of 
liver toxicity associated to the use of methotrexate (Gupta et al., 1993; Higgins et al., 1994; 
Liu et al., 2010; Qureshi et al., 2010; Smith & Fenske, 2000). 
The exact mechanism by which alcohol causes or aggravates psoriasis is not yet fully 
clarified. Some authors propose that alcohol induces immunological dysfunction, leading to 
immunosuppression, and increases the production of inflammatory cytokines and cell cycle 
activators, such as cyclin D1 and keratinocyte growth factor, which could lead to epidermal 
over-proliferation (Farkas et al., 2003; Ockenfels et al., 1996; Smith & Fenske, 2000). 
Moreover, the greater susceptibility to superficial infection observed in alcoholics, such as 
those caused by Streptococcus and trauma, has also been suggested in the development of 
psoriasis (Farkas et al., 2003). 
Data from literature indicates that alcohol is a risk factor for psoriasis in young and middle-
aged men and, while not a risk factor in women, alcohol intake aggravates the condition in 
this gender (Poikolainen et al., 1994). Patients with psoriasis are recommended to exercise 
with caution when consuming alcohol, especially during periods of exacerbation. Moreover, 
due to all possible effects, a number of authors recommend abstention (Behnam et al., 2005; 
Wolters, 2005). Thus, identifying this risk factor in patients with psoriasis could contribute 
toward a reduction in episodes of exacerbation, thereby achieving better treatment results 
(Kazakevich et al., 2011). 
11. Obesity 
The first associations between psoriasis and obesity were reported in large epidemiological 
studies carried out in Europe (Duarte et al., 2010). A pioneering American study conducted 
in the state of Utah reports a 34% prevalence of obesity among individuals with psoriasis, 
which is much higher than the 18% reported in the general population (Herron et al., 2005) 
Obesity is known to cause a state of chronic inflammation, with high levels of TNF-ǂ, IL-6 
and C-reactive protein, which are associated to the progressive increase in body mass index 
(BMI). In this state of chronic inflammation, alterations in resistance/sensitivity to insulin 
and greater oxidative stress, with the production of free radicals, lead to a greater likelihood 
of the development of diabetes and metabolic syndrome as well as the influence of these 
pro-inflammatory cytokines in the course and presentation of psoriasis (Hamminga et al., 
2006; Wakkee et al., 2007). The association between obesity and psoriasis has been well 
established, as obesity can increase the risk of developing psoriasis and preexisting psoriasis 
can increase the risk of patients becoming obese (Farías et al., 2011). 
Non-pharmacological treatment aimed at changes in lifestyle should be offered to all 
patients, especially those with a BMI ≥ 25 kg/m², for whom the goal is controlled, healthy 
weight loss (Farías et al., 2011). A low-calorie diet is recommended, following the Step I diet 
(Obesity Society, 2000) (Table 1), with a calorie restriction of 500 to 1000 kilocalories per day, 
based on the patient’s energy expenditure, which can be determined through measurement 
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techniques such as indirect calorimetry or through mathematical formulas such as the 
Harris-Benedict equation (Table 2) (Frankenfield et al., 1998).  For greater compliance to 
treatment and patient follow up, the participation of a nutritionist is needed to individualize 
the treatment, considering all socioeconomic and cultural aspects. Farías et al (2011) 
suggests the recommendations of the Nutrition Committee of the American Heart 
Association (Table 3 e Table 4). 
 
Nutrient Recommendation intake
Reducing calories Approximately 500 to 1,000 kilocalories / day 
Total fat < 30% of total calories 
Saturated fat 8 a 10% of total calories 
Monounsaturated fat ≤15% of total calories 
Polyunsaturated fat ≤10% of total calories 
Total cholesterol <300 mg / day 
Proteins Approximately 15% of total calories 
Carbohydrates At least 55% of total calories 
Sodium 100 mmol / day (approximately 2.4 g of sodium) 
Calcium 1.000 to 1.500 mg/Day 
Fiber 20 a 30 g/Day 
Table 1. Diet Step 1 (Obesity Society, 2000). 
 
Women 
BMR = 655 + (4.35 x weight in pounds ) + 
(4.7 x height in inches) - (4.7 x age in years) 
Men 
66 + (6.23 x weight in pounds) +  
(12.7 x height in inches) - (6.8 x age in years) 
Table 2. Basal metabolic rate according to the Harris  Benedict formula. 
 
Balance calorie intake and physical activity to achieve or maintain a healthy body weight. 
Consume a diet rich in vegetables and fruits.
Choose whole-grain, high-fiber foods
Consume fish, especially oily fish, at least twice a week.
Limit your intake of saturated fat to _7% of energy, trans fat to _1% of energy, and 
cholesterol to _300 mg per day by 
-Choosing lean meats and vegetable alternatives; 
— Selecting fat-free (skim), 1%-fat, and low-fat dairy products; and 
— Minimizing intake of partially hydrogenated fats. 
Minimize your intake of beverages and foods with added sugars. 
Choose and prepare foods with little or no salt.
If you consume alcohol, do so in moderation.
When you eat food that is prepared outside of the home, follow the AHA Diet and 
Lifestyle Recommendations. 
Table 3. Diet and Lifestyle Recommendations for Cardiovascular Disease  Risk 
Reduction (American Heart Association Commitee Nutrition, (AHA) 2006). 
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Lifestyle 
 
 Know your caloric needs to achieve and maintain a healthy 
weight. 
 Know the calorie content of the foods and beverages you 
consume. 
 Track your weight, physical activity, and calorie intake. 
 Prepare and eat smaller portions. 
 Track and, when possible, decrease screen time (eg, watching 
television, surfing the Web, playing computer games). 
 Incorporate physical movement into habitual activities. 
 Do not smoke or use tobacco products. 
 If you consume alcohol, do so in moderation (equivalent of no 
more than 1 drink in women or 2 drinks in men per day). 
Food choices and 
preparation 
 Use the nutrition facts panel and ingredients list when choosing 
foods to buy. 
 Eat fresh, frozen, and canned vegetables and fruits without high-
calorie sauces and added salt and sugars. 
 Replace high-calorie foods with fruits and vegetables. 
 Increase fiber intake by eating beans (legumes), whole-grain 
products, fruits, and vegetables. 
 Use liquid vegetable oils in place of solid fats. 
 Limit beverages and foods high in added sugars. Common forms 
of added sugars are sucrose, glucose, fructose, maltose, dextrose, 
corn syrups, concentrated fruit juice, and honey. 
 Choose foods made with whole grains. Common forms of whole 
grains are whole wheat, oats/oatmeal, rye, barley, corn, popcorn, 
brown rice, wild rice, buckwheat, triticale, bulgur (cracked 
wheat), millet, quinoa, and sorghum. 
 Cut back on pastries and high-calorie bakery products (eg, 
muffins, doughnuts). 
 Select milk and dairy products that are either fat free or low fat. 
 Reduce salt intake by 
- comparing the sodium content of similar products (eg, different 
brands of tomato sauce) and choosing products with less salt; 
- choosing versions of processed foods, including cereals and 
baked goods, that are reduced in salt; and 
- limiting condiments (eg, soy sauce, ketchup). 
 Use lean cuts of meat and remove skin from poultry before 
eating. 
 Limit processed meats that are high in saturated fat and 
sodium. 
 Grill, bake, or broil fish, meat, and poultry. 
 Incorporate vegetable-based meat substitutes into favorite 
recipes. 
 Encourage the consumption of whole vegetables and fruits in 
place of juices.
Table 4. Practical Tips to Implement AHA 2006 Diet and Lifestyle Recommendations. 
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12. Psoriasis and metabolic syndrome 
Metabolic syndrome is a set of metabolic alterations, particularly insulin resistance, which, 
together, lead to a greater risk of pro-inflammatory and pro-thrombotic alterations. A 
number of studies have suggested an increase in the prevalence of the components of 
metabolic syndrome in patients with psoriasis (Cohen et al., 2008; Neimann et al., 2006; 
Sommer et al., 2006). 
Patients with psoriasis have a greater prevalence of metabolic syndrome in comparison to 
those with other dermatological conditions (30.1% vs 20.6%; OR: 1.65; 95%CI: 1.16 to 2.35) 
(Gisondi et al., 2007). However, few studies have considered the possibility of associating 
the treatment for psoriasis with the components of metabolic syndrome (Fu &Vender, 
2011). A case report of a patient with psoriasis and metabolic syndrome suggests that the 
treatment program designed by nutritionists and endocrinologists through the 
modification of diet and treatment of comorbidities provided an improvement in blood 
glucose, cholesterol and BMI, along with a clinical improvement in psoriasis (Saraceno et 
al., 2008). 
13. Conclusion 
Diet is an important factor in the etiology and pathogenesis of psoriasis. Low-calorie and 
vegetarian diets may be beneficial to the treatment of this condition. Although the results 
regarding the oral supplementation of fish oil are inconsistent, patients are recommended 
to consume fish rich in omega 3 PUFAs and parenteral infusions of PUFAs are 
recommended for patients hospitalized with acute psoriasis. Further studies are needed to 
clarify the role of a gluten-free diet, which may improve the severity of the disease in 
patients with IgA and/or IgG antigliadin antibodies. Moreover, the consumption of fruit 
and vegetables may be beneficial due to their high antioxidant content. Vitamin D is an 
important treatment option due to its immuno-regulating and anti-proliferation activity. 
Patients with psoriasis should not consume alcoholic beverages in order to avoid 
exacerbation of the disease.  
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